The Case for and Against Puma Biotechnology, Inc. (PBYI) – StockNewsJournal

Posted: Published on June 7th, 2017

This post was added by Dr P. Richardson


Analyst Ratings
The Case for and Against Puma Biotechnology, Inc. (PBYI)
StockNewsJournal
Puma Biotechnology, Inc. (PBYI) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $83.65, up from yesterday's close by 2.07%. Given the stock's recent action, it ...
What Should Investors Make Of The Trading Chart Of Puma Biotechnology, Inc. (PBYI)?NY Stock News
Summary of Stock Move: Puma Biotechnology, Inc. (PBYI), Intrexon Corporation (XON)The Momentous News
Adage Capital Partners Gp, LL Sells 507128 Shares of Puma Biotechnology Inc (PBYI) StockBNB Daily (blog)
Analyst Ratings -The Cerbat Gem -StockNewsMagazine -Zacks
all 38 news articles »

See original here:
The Case for and Against Puma Biotechnology, Inc. (PBYI) - StockNewsJournal

Related Posts
This entry was posted in Biotechnology. Bookmark the permalink.

Comments are closed.